BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 8202154)

  • 1. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand.
    de Sauvage FJ; Hass PE; Spencer SD; Malloy BE; Gurney AL; Spencer SA; Darbonne WC; Henzel WJ; Wong SC; Kuang WJ
    Nature; 1994 Jun; 369(6481):533-8. PubMed ID: 8202154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo.
    Lok S; Kaushansky K; Holly RD; Kuijper JL; Lofton-Day CE; Oort PJ; Grant FJ; Heipel MD; Burkhead SK; Kramer JM
    Nature; 1994 Jun; 369(6481):565-8. PubMed ID: 8202158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cMpl ligand is a humoral regulator of megakaryocytopoiesis.
    Wendling F; Maraskovsky E; Debili N; Florindo C; Teepe M; Titeux M; Methia N; Breton-Gorius J; Cosman D; Vainchenker W
    Nature; 1994 Jun; 369(6481):571-4. PubMed ID: 8202160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin and the humoral regulation of thrombocytopoiesis.
    Eaton DL; de Sauvage FJ
    Curr Opin Hematol; 1995 May; 2(3):167-71. PubMed ID: 9371990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombocytopenia in c-mpl-deficient mice.
    Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW
    Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombopoietin, the c-mpl ligand, is a major regulator of platelet production.
    Broudy VC; Kaushansky K
    J Leukoc Biol; 1995 May; 57(5):719-25. PubMed ID: 7759951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-mpl, the thrombopoietin receptor.
    Vainchenker W; Methia N; Debili N; Titeux M; Wendling F
    Thromb Haemost; 1995 Jul; 74(1):526-8. PubMed ID: 8578519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
    Drexler HG; Quentmeier H
    Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.
    Deutsch VR; Tomer A
    Br J Haematol; 2013 Jun; 161(6):778-93. PubMed ID: 23594368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
    Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
    Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin.
    Kaushansky K; Lok S; Holly RD; Broudy VC; Lin N; Bailey MC; Forstrom JW; Buddle MM; Oort PJ; Hagen FS
    Nature; 1994 Jun; 369(6481):568-71. PubMed ID: 8202159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure, biology and potential therapeutic applications of recombinant thrombopoietin.
    Lok S; Foster DC
    Stem Cells; 1994 Nov; 12(6):586-98. PubMed ID: 7881359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl.
    Bartley TD; Bogenberger J; Hunt P; Li YS; Lu HS; Martin F; Chang MS; Samal B; Nichol JL; Swift S
    Cell; 1994 Jul; 77(7):1117-24. PubMed ID: 8020099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of c-mpl ligand on cytoplasmic maturation of murine megakaryocytes and on platelet production.
    Ishida Y; Ito T; Kuriya Si
    J Histochem Cytochem; 1998 Jan; 46(1):49-57. PubMed ID: 9405494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of megakaryocytopoiesis by thrombopoietin.
    McDonald TP
    Ann N Y Acad Sci; 1987; 509():1-24. PubMed ID: 3322129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation.
    Nagahisa H; Nagata Y; Ohnuki T; Osada M; Nagasawa T; Abe T; Todokoro K
    Blood; 1996 Feb; 87(4):1309-16. PubMed ID: 8608219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin: the primary regulator of megakaryocyte and platelet production.
    Kaushansky K
    Thromb Haemost; 1995 Jul; 74(1):521-5. PubMed ID: 8578518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombopoietin from beginning to end.
    Hitchcock IS; Kaushansky K
    Br J Haematol; 2014 Apr; 165(2):259-68. PubMed ID: 24499199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways.
    Doshi PD; Giri JG; Abegg AL; Favara JP; Huynh MS; Kahn LE; Minnerly JC; Pegg LE; Villani-Price D; Siegel NR; Staten NR; Thomas JW; McKearn JP; Smith WG
    Exp Hematol; 2001 Oct; 29(10):1177-84. PubMed ID: 11602319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of human leukemia-lymphoma cell lines in hematological research: effects of thrombopoietin on human leukemia cell lines.
    Drexler HG; Quentmeier H
    Hum Cell; 1996 Dec; 9(4):309-16. PubMed ID: 9183663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.